"Paliperidone Palmitate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.
| Descriptor ID |
D000068882
|
| MeSH Number(s) |
D03.383.129.385.650 D03.383.742.592
|
| Concept/Terms |
Paliperidone- Paliperidone
- 9-OH-risperidone
- 9 OH risperidone
- 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
- 9-Hydroxy-risperidone
- 9 Hydroxy risperidone
- 9-Hydroxyrisperidone
- 9 Hydroxyrisperidone
|
Below are MeSH descriptors whose meaning is more general than "Paliperidone Palmitate".
Below are MeSH descriptors whose meaning is more specific than "Paliperidone Palmitate".
This graph shows the total number of publications written about "Paliperidone Palmitate" by people in this website by year, and whether "Paliperidone Palmitate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Paliperidone Palmitate" by people in Profiles.
-
Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison. Int Clin Psychopharmacol. 2017 09; 32(5):235-248.
-
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32.
-
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents. J Child Adolesc Psychopharmacol. 2011 Apr; 21(2):163-9.